Nu Skin director granted 26,643 shares of stock
Thomas Pisano R. reported acquisition or exercise transactions in this Form 4 filing.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Thomas Pisano R. reported acquisition or exercise transactions in this Form 4 filing.
NU SKIN ENTERPRISES, INC. director Thomas R. Pisano received a grant of Class A Common Stock as equity compensation. On June 1, 2026, he was awarded 26,643 shares at no purchase price, reflecting a stock-based award rather than an open-market buy. Following this grant, he directly holds 116,827 shares of Nu Skin Class A Common Stock, indicating the transaction increased his equity stake through a routine compensation-related award.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Class A Common Stock | 26,643 | $0.00 | $0.00 |
Key Figures
Key Terms
Class A Common Stock financial
Grant, award, or other acquisition financial
non-derivative financial
direct financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Nu Skin (NUS) director Thomas R. Pisano report on this Form 4?
Was the Nu Skin (NUS) Form 4 transaction a market buy or a compensation grant?
AI-generated analysis. How Rhea-AI works. Not financial advice.